click below
click below
Normal Size Small Size show me how
ID 1,2
| Pharmacologic Category | Generic Name | Brand Name | Common Indication |
|---|---|---|---|
| Beta-lactam antibiotic (natural penicillin) | penicillin V potassium (PO), penicillin G potassium (IV) | Pharyngitis, SSTI, syphilis (IV,IM) ACTIVITY AGAINST: Streptococcus pyogenes, Treponema pallidum (syphilis) | |
| Beta-lactam antibiotic (aminopenicillin) | amoxicillin (PO) | Otitis media, pharyngitis ACTIVITY AGAINST: Streptococcus pneumoniae, Streptococcus pyogenes | |
| Beta-lactam antibiotic and beta-lactamase inhibitor | amoxicillin and clavulanate (PO) | Augmentin, Augmentin XR | Otitis media, bacterial sinusitis ACTIVITY AGAINST: MSSA, Streptococcus pneumoniae, anaerobes, Enterobacteriacae |
| Beta-lactam antibiotic and beta-lactamase inhibitor | ampicillin and sulbactam (IV) | Unasyn | DFI, IAI ACTIVITY AGAINST: MSSA, Streptococcus pneumoniae, anaerobes, Enterobacteriacae |
| Bata-lactam antibiotic and beta-lactamase inhibitor | piperacillin and tazobactam (IV) | Zosyn | HAP, VAP, DFI, IAI ACTIVITY AGAINST: Pseudomonas aeruginosa, anaerobes |
| Beta-lactam antibiotic (first generation cephalosporin) | cephalexin (PO) | Keflex | SSTI ACTIVITY AGAINST: MSSA, Streptococcus pyogenes |
| Beta-lactam antibiotic (first generation cephalosporin) | cefazolin (IV) | Ancef | Antimicrobial prophylaxis in surgery, CRBSI, SSTI ACTIVITY AGAINST: MSSA, Streptococcus pyogenes |
| Beta-lactam antibiotic (second generation cephalosporin) | cefuroxime (IV, PO) | IV: Zinacef, PO: Ceftin | CAP, otitis media ACTIVITY AGAINST: Streptococcus pneumoniae, Haemophilus influenzae |
| Beta-lactam antibiotic (third generation cephalosporin) | cefdinir (PO) | Omnief | Otitis media, bacterial sinusitis ACTIVITY AGAINST: Streptococcus pneumoniae, Haemophilus influenzae |
| Beta-lactam antibiotic (third generation cephalosporin) | ceftriaxone (IV, IM) | Rocephin | Meningitis, CAP, pyelonephritis ACTIVITY AGAINST: Streptococcus pneumoniae, Enterobacteriaceae |
| Beta-lactam antibiotic (fourth generation cephalosporin) | cefepime (IV) | Maxipime | Meningitis, VAP, HAP, pyelonephritis ACTIVITY AGAINST: Pseudomonas aeruginosa, Enterobacteriaceae |
| Carbapenem | meropenem (IV) | Merrem | Meningitis, HAP, DFI, IAI ACTIVITY AGAINST: Pseudomonas aeruginosa, ESBL-producing Enterobacteriaceae |
| Carbapenem | ertapenem (IV) | Invanz | DFI, IAI ACTIVITY AGAINST: ESBL- producing Enterobacteriaceae |
| Fluoroquinolone antibiotic | ciprofloxacin (PO, IV) | Cipro | Pyelonephritis, HAP, VAP ACTIVITY AGAINST: Pseudomonas aeruginosa, atypicals, Enterobacteriaceae |
| Fluoroquinolone antibiotic | levofloxacin (PO, IV) | Levaquin | CAP, HAP, VAP, pyelonephritis ACTIVITY AGAINST: Pseudomonas aeruginosa, Streptococcus pneumoniae, atypicals, Enterobacteriaceae |
| Fluoroquinolone antibiotic | moxifloxacin (ophthalmic, PO, IV) | Ophthalmic, Vigamox, PO, IV: Avelox | Ophthalmic bacterial conjunctivitis, PO, IV: CAP ACTVITIY AGAINST: Streptococcus pneumoniae, atypicals, tuberculosis |
| Macrolide antibiotic | azithromycin (PO, IV) | Zithromax, Z-Pak, Zmax | CAP ACTIVITY AGAINST: Chlamydia trachomatis, atypicals |
| Macrolide antibiotic | fidaxomicin (PO) | Dificid | CDI ACTIVITY AGAINT: Clostridioides difficile |
| Tetracycline antibiotic | doxycycline (PO, IV) | Vibramycin | SSTI, CAP, tickborn diseases ACTIVITY AGAINST: MRSA, atypicals |
| Tetracycline antibiotic | minocycline (PO,IV) | Minocin | SSTI, acne ACTIVITY AGAINST: MRSA |